179. Williams syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 5 / Drugs : 14 - (DrugBank : 7) / Drug target genes : 8 - Drug target pathways : 32
Drugs and their primary sponsors and trial info
Buspirone
Massachusetts General Hospital
2021 Phase 4 NCT04807517 United States;
COZAAR 50 mg comprimidos recubierto con pelicula
Programa de Medicina Molecular y Genética, Hospital Vall d´Hebron
2009 - EUCTR2007-006059-37-ES Spain;
LONOTEN
Hospices Civils de Lyon
2008 - EUCTR2006-005745-11-FR France;
LOSARTAN POTASICO
Programa de Medicina Molecular y Genética, Hospital Vall d´Hebron
2009 - EUCTR2007-006059-37-ES Spain;
LOSARTAN POTASSIUM
Programa de Medicina Molecular y Genética, Hospital Vall d´Hebron
2009 - EUCTR2007-006059-37-ES Spain;
Methylphenidate, fluoxetin, risperidone
The Chaim Sheba Medical Center
2001 Phase 4 NCT00768820 Israel;
Vitamin D
National Center for Research Resources (NCRR)
1998 - NCT00013962 United States;
Massachusetts General Hospital
2021 Phase 4 NCT04807517 United States;
COZAAR 50 mg comprimidos recubierto con pelicula
Programa de Medicina Molecular y Genética, Hospital Vall d´Hebron
2009 - EUCTR2007-006059-37-ES Spain;
LONOTEN
Hospices Civils de Lyon
2008 - EUCTR2006-005745-11-FR France;
LOSARTAN POTASICO
Programa de Medicina Molecular y Genética, Hospital Vall d´Hebron
2009 - EUCTR2007-006059-37-ES Spain;
LOSARTAN POTASSIUM
Programa de Medicina Molecular y Genética, Hospital Vall d´Hebron
2009 - EUCTR2007-006059-37-ES Spain;
Methylphenidate, fluoxetin, risperidone
The Chaim Sheba Medical Center
2001 Phase 4 NCT00768820 Israel;
Vitamin D
National Center for Research Resources (NCRR)
1998 - NCT00013962 United States;